The non-invasive assay for Down Syndrome detection in prenatal testing is a significant advancement, offering a safer and more reliable alternative to traditional invasive methods like amniocentesis. This technique, which analyzes fetal DNA from a maternal blood sample, reduces risk and anxiety for